1. Home
  2. ELTX vs PLCE Comparison

ELTX vs PLCE Comparison

Compare ELTX & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$1.90

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

Logo Children's Place Inc. (The)

PLCE

Children's Place Inc. (The)

HOLD

Current Price

$1.04

Market Cap

62.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
PLCE
Founded
2011
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
62.0M
IPO Year
2014
1997

Fundamental Metrics

Financial Performance
Metric
ELTX
PLCE
Price
$1.90
$1.04
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $13.67
N/A
AVG Volume (30 Days)
258.8K
★ 277.7K
Earning Date
11-12-2026
09-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 39.29
11.48
EPS
★ N/A
N/A
Revenue
★ $2,301,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.75
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.44
$1.00
52 Week High
$16.00
$9.56

Technical Indicators

Market Signals
Indicator
ELTX
PLCE
Relative Strength Index (RSI) 48.08 15.87
Support Level $1.74 N/A
Resistance Level $1.97 $2.88
Average True Range (ATR) 0.15 0.12
MACD 0.04 -0.03
Stochastic Oscillator 79.63 2.24

Price Performance

Historical Comparison
ELTX
PLCE

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About PLCE Children's Place Inc. (The)

Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.

Share on Social Networks: